Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

The Cochrane Database of Systematic Reviews
Matthew N HurleyAlan R Smyth

Abstract

Cystic fibrosis is a multi-system disease characterised by the production of thick secretions causing recurrent pulmonary infection, often with unusual bacteria. This leads to lung destruction and eventually death through respiratory failure. There are no antibiotics in development that exert a new mode of action and many of the current antibiotics are ineffective in eradicating the bacteria once chronic infection is established. Antibiotic adjuvants - therapies that act by rendering the organism more susceptible to attack by antibiotics or the host immune system, by rendering it less virulent or killing it by other means, would be a significant therapeutic advance. This is an update of a previously published review. To determine if antibiotic adjuvants improve clinical and microbiological outcome of pulmonary infection in people with cystic fibrosis. We searched the Cystic Fibrosis Trials Register which is compiled from database searches, hand searches of appropriate journals and conference proceedings. Date of most recent search: 16 January 2020. We also searched MEDLINE (all years) on 14 February 2019 and ongoing trials registers on 06 April 2020. Randomised controlled trials and quasi-randomised controlled trials of a thera...Continue Reading

References

Feb 1, 1989·The Journal of Pediatrics·G B WinnieN A Wade
Sep 1, 1995·The Journal of Pediatrics·D N HomnickT V Ringer
May 15, 1998·The Journal of Pediatrics·B J Rosenstein, G R Cutting
Sep 20, 2001·The Journal of Pediatrics·M RosenfeldB Ramsey
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Dec 6, 2005·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Alice PanchaudMichel Roulet
Mar 28, 2006·Experimental Biology and Medicine·Jan BorysowskiAndrzej Górski
Jun 20, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Lakshmi DurairajJoseph Zabner
Dec 22, 2006·The European Respiratory Journal·J A DodgeJ Wilsher
Mar 28, 2007·Thorax·Christopher H Goss, Jane L Burns
May 6, 2008·Journal of Bacteriology·Susanne B von BodmanStephen P Diggle
Aug 6, 2008·Pediatric Pulmonology·Elin NilssonHans Kollberg
Aug 9, 2008·Médecine et maladies infectieuses·M Kutateladze, R Adamia
Dec 2, 2008·International Journal of Medical Sciences·Hans-Peter HauberUdo Schumacher
Oct 31, 2009·International Journal of Cancer. Journal International Du Cancer·Nathalie Druesne-PecolloSerge Hercberg
Feb 9, 2010·Journal of Medicinal Food·L C LandsY Berthiuame
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Matthew N HurleyAlan R Smyth
Oct 22, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Scott D SagelKonstantinos A Papas
Jan 28, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Anissa LeonardTeresinha Leal
Sep 22, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Richard B MossUNKNOWN CF2110399 Investigators
Jan 22, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·H GrasemannF Ratjen
Jun 6, 2013·The Cochrane Database of Systematic Reviews·Matthew N HurleyAlan R Smyth
Sep 11, 2013·Pediatric Pulmonology·Carlos E MillaUNKNOWN KB001 Study Group
Feb 18, 2014·BMC Pulmonary Medicine·Emily DimangoXinhua Liu
Nov 2, 2014·The European Respiratory Journal·Anna MiddletonHiran Selvadurai
Nov 11, 2014·The Cochrane Database of Systematic Reviews·Simon C Langton Hewer, Alan R Smyth
Jun 17, 2015·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Moon Jeong LeeUNKNOWN Vitamin D for Enhancing the Immune System in Cystic Fibrosis Investigators
Oct 30, 2015·The American Journal of the Medical Sciences·Moon Jeong LeeVin Tangpricha
Dec 29, 2015·Pediatric Pulmonology·Doug L ForresterAndrew W Fogarty
Jul 29, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert P HowlinJeremy S Webb
Jan 3, 2018·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Raksha JainUNKNOWN KB001-A Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Raksha JainKB001-A Study Group
The Cochrane Database of Systematic Reviews
Matthew N HurleyAlan R Smyth
The Cochrane Database of Systematic Reviews
Matthew N HurleyAlan R Smyth
The Cochrane Database of Systematic Reviews
Sherie SmithEdward Charbek
The Cochrane Database of Systematic Reviews
Larry C Lands, Sanja Stanojevic
© 2021 Meta ULC. All rights reserved